Three patient deaths linked to gene therapies developed by Sarepta Therapeutics (SRPT) have drawn FDA scrutiny on the viral ...

CBER is unanimously against Elevdiys’ return to the market without additional evidence, according to media reports citing an ...

In this week’s edition of InnovationRx, we look at Moderna’s use of quantum computers, a new top drug regulator at the FDA, ...

This rib bone discovered in a cave in the Spanish Pyrenees tells a story of Bronze Age violence. But who fired the shot?

Sarepta Therapeutics' recent setbacks and restructuring have pressured Arrowhead's share price. Read why I am reiterating my bullish rating on ARWR stock.

Our approach to implementing social impact starts with our own purpose, to empower every person and every organisation on the planet to achieve more.

Shares of Sarepta Therapeutics SRPT are declining in the pre-market hours today after the announcement that it will ...

Shares of Sarepta Therapeutics SRPT nosedived 35.9% on Friday following the death of a patient dosed with one of its ...